Healthcare Sales & Marketing Network News: Ambrilia Biopharma

Searching News Database: Ambrilia Biopharma

HSMN NewsFeed - 31 Mar 2010
Ambrilia Biopharma Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Feb 2008
Ambrilia Announces the Departure of Dr. Chandra J. Panchal, Executive Vice-President, Business Development, Licensing and IP
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jun 2007
Ambrilia Appoints a New Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Apr 2007
Ambrilia Announces the Appointment of Stephen G. Sudovar as Executive Chairman & Interim CEO as Hans Mader is Stepping Down as President & CEO and a $5.4 Million Private Placement
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2006
Ambrilia Announces European Licensing Partnership with TEVA for its Lead Oncology Product, Octreotide
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Nov 2006
Study Shows Ambrilia's PSP94 Immunoassay to Have Prognostic Value in Prostate Cancer Management
Biopharmaceuticals Diagnostics Oncology Urology

HSMN NewsFeed - 12 Oct 2006
Ambrilia Biopharma and Merck & Co., Inc. Sign Licensing Agreement Granting Merck Worldwide Rights to Ambrilia's HIV/AIDS Protease Inhibitor Program
Biopharmaceuticals Licensing HIV/AIDS

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.